Cytori Therapeutics Inc Stock Nasdaq
Equities
US23283K2042
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 3.4M | Sales 2025 * | 4.28M | Capitalization | 7.23M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | -22M | EV / Sales 2024 * | 2.13 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.69 x |
P/E ratio 2024 * |
-0.74
x | P/E ratio 2025 * |
-0.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.77% |
Latest transcript on Cytori Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 02-09-30 |
Andrew Sims
DFI | Director of Finance/CFO | 51 | 20-02-05 |
Pius Maliakal
CTO | Chief Tech/Sci/R&D Officer | - | 23-07-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 02-09-30 |
Richard Hawkins
CHM | Chairman | 75 | 07-11-30 |
Robert Lenk
BRD | Director/Board Member | 75 | 20-02-29 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |